nelremagpran   Click here for help

GtoPdb Ligand ID: 14678

Synonyms: Compound 1-55 [WO2020198537] | EP547
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Nelremagpran (likely company research code EP547, Escient Pharmaceuticals) is a Mas-related G protein-coupled receptor MRGPRX4 antagonist [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 46.53
Molecular weight 348.68
XLogP 2.83
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CC(=C(C(=C1)COC2=CC=C(C=C2Cl)C(F)(F)F)F)C(=O)O
Isomeric SMILES C1=CC(=C(C(=C1)C(=O)O)F)COC2=C(C=C(C=C2)C(F)(F)F)Cl
InChI InChI=1S/C15H9ClF4O3/c16-11-6-9(15(18,19)20)4-5-12(11)23-7-8-2-1-3-10(13(8)17)14(21)22/h1-6H,7H2,(H,21,22)
InChI Key TWOXPNAILYKJPT-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
EP547 was progressed as a clinical candidate, for potential to treat pruritic skin inflammation.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04510090 Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus Phase 1 Interventional Escient Pharmaceuticals, Inc
NCT05525520 Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis Phase 2 Interventional Escient Pharmaceuticals, Inc